The global surgical imaging market size is accounted at USD 5.76 billion in 2025 and is forecasted to hit around USD 9.60 billion by 2034, representing a CAGR of 5.84% from 2025 to 2034. The North America market size was estimated at USD 1.90 billion in 2024 and is expanding at a CAGR of 6.02% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Surgical Imaging Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Surgical Imaging Market, by Modality, 2025-2034
8.1.1 C-arms
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Computed Tomography
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. X-ray
8.1.3.1. Market Revenue and Forecast (2022-2034)
8.1.4. Ultrasound
8.1.4.1. Market Revenue and Forecast (2022-2034)
9.1. Surgical Imaging Market, by Application, 2025-2034
9.1.1. Neurosurgeries
9.1.1.1. Market Revenue and Forecast (2022-2034)
9.1.2. Cardiovascular Surgeries
9.1.2.1. Market Revenue and Forecast (2022-2034)
9.1.3. Orthopedic and Trauma
9.1.3.1. Market Revenue and Forecast (2022-2034)
9.1.4. Gynecological Surgeries
9.1.4.1. Market Revenue and Forecast (2022-2034)
9.1.5. Thoracic Surgeries
9.1.5.1. Market Revenue and Forecast (2022-2034)
9.1.6. Urological Surgeries
9.1.6.1. Market Revenue and Forecast (2022-2034)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2022-2034)
10.1. Surgical Imaging Market, by End-use, 2025-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2022-2034)
10.1.2. Specialty Clinics
10.1.2.1. Market Revenue and Forecast (2022-2034)
10.1.3. Ambulatory Surgical Centers
10.1.3.1. Market Revenue and Forecast (2022-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2022-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Modality (2022-2034)
11.1.2. Market Revenue and Forecast, by Application (2022-2034)
11.1.3. Market Revenue and Forecast, by End-use (2022-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Modality (2022-2034)
11.1.4.2. Market Revenue and Forecast, by Application (2022-2034)
11.1.4.3. Market Revenue and Forecast, by End-use (2022-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Modality (2022-2034)
11.1.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.1.5.3. Market Revenue and Forecast, by End-use (2022-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Modality (2022-2034)
11.2.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.3. Market Revenue and Forecast, by End-use (2022-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Modality (2022-2034)
11.2.4.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.4.3. Market Revenue and Forecast, by End-use (2022-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Modality (2022-2034)
11.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.5.3. Market Revenue and Forecast, by End-use (2022-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Modality (2022-2034)
11.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.6.3. Market Revenue and Forecast, by End-use (2022-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Modality (2022-2034)
11.2.7.2. Market Revenue and Forecast, by Application (2022-2034)
11.2.7.3. Market Revenue and Forecast, by End-use (2022-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Modality (2022-2034)
11.3.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.3. Market Revenue and Forecast, by End-use (2022-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Modality (2022-2034)
11.3.4.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.4.3. Market Revenue and Forecast, by End-use (2022-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Modality (2022-2034)
11.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.5.3. Market Revenue and Forecast, by End-use (2022-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Modality (2022-2034)
11.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.6.3. Market Revenue and Forecast, by End-use (2022-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Modality (2022-2034)
11.3.7.2. Market Revenue and Forecast, by Application (2022-2034)
11.3.7.3. Market Revenue and Forecast, by End-use (2022-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Modality (2022-2034)
11.4.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.3. Market Revenue and Forecast, by End-use (2022-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Modality (2022-2034)
11.4.4.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.4.3. Market Revenue and Forecast, by End-use (2022-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Modality (2022-2034)
11.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.5.3. Market Revenue and Forecast, by End-use (2022-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Modality (2022-2034)
11.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.6.3. Market Revenue and Forecast, by End-use (2022-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Modality (2022-2034)
11.4.7.2. Market Revenue and Forecast, by Application (2022-2034)
11.4.7.3. Market Revenue and Forecast, by End-use (2022-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Modality (2022-2034)
11.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.5.3. Market Revenue and Forecast, by End-use (2022-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Modality (2022-2034)
11.5.4.2. Market Revenue and Forecast, by Application (2022-2034)
11.5.4.3. Market Revenue and Forecast, by End-use (2022-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Modality (2022-2034)
11.5.5.2. Market Revenue and Forecast, by Application (2022-2034)
11.5.5.3. Market Revenue and Forecast, by End-use (2022-2034)
12.1. Koninklijke Philips N.V.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GE Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Siemens Healthcare GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Ziehm Imaging GmbH
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Shimadzu Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Hologic Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. FUJIFILM Holdings America Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. CANON MEDICAL SYSTEMS CORPORATION
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. SAMSUNG HEALTHCARE
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample